MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./280/0.1/21.03.25 Share Price

Warrant

DE000MG0Y1L3

Real-time Bid/Ask 04:00:42 27/06/2024 pm IST
0.52 EUR / 0.57 EUR +0.93% Intraday chart for MORGAN STANLEY PLC/CALL/BECTON DICKINSON AND CO./280/0.1/21.03.25
Current month+35.00%
1 month+38.46%
Date Price Change
27/24/27 0.52 -3.70%
26/24/26 0.54 -6.90%
25/24/25 0.58 +5.45%
24/24/24 0.55 -9.84%
21/24/21 0.61 -3.17%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 01:39 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG0Y1L
ISINDE000MG0Y1L3
Date issued 27/03/2024
Strike 280 $
Maturity 21/03/2025 (268 Days)
Parity 10 : 1
Emission price 0.82
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.12
Lowest since issue 0.31
Spread 0.05
Spread %8.93%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus